GOSS — Gossamer Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Gossamer Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	402	513	325	256	296
Prepaid Expenses
Total Other Current Assets
Total Current Assets	409	522	332	262	307
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15.7	16.1	10.8	9.89	4.78
Other Long Term Assets
Total Assets	427	539	344	272	312
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	36.9	38.6	39.9	49.2	51.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	74.1	219	222	260	249
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	352	321	121	12.1	62.8
Total Liabilities & Shareholders' Equity	427	539	344	272	312
Total Common Shares Outstanding